This bill establishes new provisions regarding chimeric antigen receptor T-cell (CAR-T) therapy within Florida's health insurance and health maintenance organization frameworks. It creates three new sections in the Florida Statutes: 627.64198, 627.6614, and 641.31078. These sections prohibit health insurers and health maintenance organizations from refusing to contract with or denying coverage for CAR-T therapy provided by certified health care facilities that are part of their provider networks. The provisions apply to policies issued, delivered, or renewed on or after January 1, 2026.

The bill ensures that any health insurance policy or health maintenance contract that includes coverage for CAR-T therapy must accept qualified providers, thereby expanding access to this critical treatment for patients. The effective date for these changes is set for January 1, 2026, allowing time for insurers and providers to adjust to the new requirements.